← Back to all earnings calls

Avalo Therapeutics, Inc. Q1 FY2023 Earnings Call

Avalo Therapeutics, Inc. (AVTX)

Earnings Call FY2023 Q1 Call date: 2023-05-04 Concluded

Share

Quarter scorecard

Revenue

$475,000

-59.5% YoY

Diluted EPS

$-204.00

Net income

$

Documents & deck